Use access key #2 to skip to page content.
$4.66 -0.06 (-1.27%)
11/21/2008 4:00 PM

Idenix Pharmaceuticals, Inc. (IDIX)

CAPS Rating:
***

A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.

X

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating IDIX

Add Stock to Watchlist

What the Community Thinks

Total Members

134 Outperforms
12 Underperforms
 

All-Stars

24 Outperforms
4 Underperforms
 

Wall Street

1 Outperforms
0 Underperforms
 

Members bullish on IDIX are also bullish on:

Members bearish on IDIX are also bearish on:

Ticker Tags

Micro Cap (5043), Biotechnology (230)
Suggest a tag

Idenix Pharmaceuticals, Inc. At A Glance

Current Price: $4.66
Last Trade Time: 11/21/2008 4:00 PM
Open: $4.75
Previous Close: $4.72
Daily Range: $3.81 - $4.75
52-Week Range: $2.10 - $10.10
Volume: 242,993
Market Cap: $266.75M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

IDIX VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for IDIX

More Headlines...

Top Bull Pitch

Recs

1

Idenix Pharmaceuticals, Inc. (IDIX)

Avatar darkflame (96.19) Submitted: 4/15/07 6:57 PM

What company is this ? Well...it's a small biotec company, Novartis owns more than 10% of it and isnt selling any shares. Novartis bought more than 4 million shares of IDIX at a price over 20 dollars per share. What's the price today ? About 7 dollars. Unfortunally relating to biotec knowledge I'm n...More

Replies: 1 | Reply | Permalink

Top Bear Pitch

Recs

1

Idenix Pharmaceuticals, Inc. (IDIX)

Avatar giftofgod (24.24) Submitted: 11/05/08 1:29 AM

Apparently, Novartis owns more than 50% of this, but Novartis is no longer reimbursing this company for the research. Sure, costs are down 50%, but revenues are down 75%. That means an increased loss. It is possible this will come back, but in this economy, I am expecting a decline, at least for the...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 22 :   1 2 3 4 5 Next »

Recs

1

 (IDIX)

Avatar giftofgod (24.24) Submitted: 11/05/08 1:29 AM : Underperform Start Price: $5.78 IDIX Score: -4.19

Apparently, Novartis owns more than 50% of this, but Novartis is no longer reimbursing this company for the research. Sure, costs are down 50%, but revenues are down 75%. That means an increased loss. It is possible this will come back, but in this economy, I am expecting a decline, at least for the short term.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (IDIX)

Avatar RNZ100 (< 20) Submitted: 10/08/08 8:28 PM : Outperform Start Price: $5.11 IDIX Score: 15.06

Oversold (but then again, what isn't?!)

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (IDIX)

Avatar tenmiles (99.99) Submitted: 1/09/08 12:40 PM : Underperform Start Price: $3.24 IDIX Score: -89.29

Forget Novartis, use today's strength to short Idenix at $3.25; techncially well overbought - looking for 15% pullback within two quarters.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (IDIX)

Avatar Biotech2008 (90.46) Submitted: 1/04/08 9:58 PM : Outperform Start Price: $2.72 IDIX Score: 117.85

CSOakes @2.51

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (IDIX)

Avatar zzlangerhans (99.48) Submitted: 12/16/07 9:55 PM : Underperform Start Price: $2.49 IDIX Score: -135.42

After the recent restructuring, it is now clear where this company stands. One HIV drug in phase I with no current plan for a phase II trial. One or two HCV drugs in preclinical development, with a history of one massive faceplant in HCV. Also a history of a very high burn rate which will obviously be reduced, but likely not as much as the company claims. 140M is simply too high of a market cap for this pipeline, and 70M would probably be more appropriate. As the company continues to bleed cash without significant progress through clinical trials in 2008, it will become clear that a dilutional financing is imminent.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 22 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 1 of 1  

picks per page. CHANGE

Top
Pick		Member NameMember RatingStart
Date		CallTime FrameStart
Price		Stock
Gain		S&P
Gain		ScorePitch
TrackCarisandCo 50.26 04/21/08 Outperform NS $6.25-25.44%-45.17%+19.73

Results 1 - 1 of 1  

X

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links